Maridea Wealth Management LLC lifted its holdings in Align Technology, Inc. (NASDAQ:ALGN – Free Report) by 125.4% during the 4th quarter, Holdings Channel.com reports. The firm owned 6,193 shares of the medical equipment provider’s stock after buying an additional 3,445 shares during the period. Maridea Wealth Management LLC’s holdings in Align Technology were worth $967,000 as of its most recent filing with the Securities & Exchange Commission.
Other institutional investors and hedge funds also recently made changes to their positions in the company. Sentry Investment Management LLC grew its position in Align Technology by 73.1% during the third quarter. Sentry Investment Management LLC now owns 187 shares of the medical equipment provider’s stock valued at $25,000 after buying an additional 79 shares during the period. Steigerwald Gordon & Koch Inc. bought a new position in Align Technology in the third quarter worth approximately $26,000. Quent Capital LLC bought a new position in Align Technology in the third quarter worth approximately $30,000. TD Private Client Wealth LLC boosted its stake in shares of Align Technology by 135.6% during the 3rd quarter. TD Private Client Wealth LLC now owns 238 shares of the medical equipment provider’s stock worth $30,000 after acquiring an additional 137 shares during the last quarter. Finally, Miller Global Investments LLC bought a new stake in shares of Align Technology during the 4th quarter valued at $31,000. Hedge funds and other institutional investors own 88.43% of the company’s stock.
Key Stories Impacting Align Technology
Here are the key news stories impacting Align Technology this week:
- Positive Sentiment: Elliott Investment Management has built a significant, reportedly “major” stake in Align, signalling potential engagement to push for actions that could boost shareholder value (strategic review, cost moves, buybacks or governance changes). This is the primary catalyst behind recent intraday upside. Elliott builds stake in Invisalign maker Align Technology – Reuters
- Positive Sentiment: Market coverage notes and press reports (Bloomberg/Yahoo) echo the stake build and include an updated company response — the combination of activist pressure plus public attention is often perceived as positive for near-term shareholder returns. Market Chatter: Activist Elliott Investment Builds Stake in Align Technology – Yahoo
- Positive Sentiment: Analyst/market reaction: ALGN saw premarket and intraday spikes on the reports and a recent upgrade to Overweight at Barclays, which may lend support to the stock if analysts follow with higher targets. Align Technology Raised to Overweight at Barclays – American Banking News
- Neutral Sentiment: Short interest posts in the data feed show zero shares (and 0 days to cover), which appears to be a reporting anomaly rather than a market signal — treat short-interest headlines with caution until clean data is published.
- Negative Sentiment: Structural headwinds remain: ALGN is still materially below its 2021 peak as dental/demand trends have normalized after the pandemic-era boom. Activist involvement can be positive but may also lead to strategic changes that create uncertainty or execution risk in the near term. Elliott Builds Major Align Stake as Shares Sit Near $172 – Yahoo
Align Technology Price Performance
Align Technology (NASDAQ:ALGN – Get Free Report) last issued its earnings results on Wednesday, February 4th. The medical equipment provider reported $3.29 earnings per share for the quarter, topping the consensus estimate of $2.99 by $0.30. Align Technology had a net margin of 10.17% and a return on equity of 15.16%. The company had revenue of $1.05 billion during the quarter, compared to the consensus estimate of $1.03 billion. During the same quarter in the prior year, the firm posted $2.44 EPS. Align Technology’s quarterly revenue was up 5.3% compared to the same quarter last year. Equities research analysts expect that Align Technology, Inc. will post 7.98 earnings per share for the current fiscal year.
Insider Activity at Align Technology
In other news, EVP John Morici sold 7,969 shares of the business’s stock in a transaction dated Wednesday, February 18th. The stock was sold at an average price of $189.31, for a total value of $1,508,611.39. Following the transaction, the executive vice president directly owned 8,237 shares in the company, valued at $1,559,346.47. The trade was a 49.17% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. 0.66% of the stock is owned by insiders.
Wall Street Analysts Forecast Growth
Several equities research analysts have recently commented on ALGN shares. UBS Group upped their price objective on Align Technology from $175.00 to $185.00 and gave the stock a “neutral” rating in a research note on Thursday, February 5th. Morgan Stanley lifted their target price on Align Technology from $154.00 to $169.00 and gave the company an “equal weight” rating in a research report on Thursday, February 5th. Wall Street Zen upgraded Align Technology from a “buy” rating to a “strong-buy” rating in a research report on Saturday, March 7th. Piper Sandler raised their price objective on Align Technology from $200.00 to $220.00 and gave the stock an “overweight” rating in a research note on Thursday, February 5th. Finally, Stifel Nicolaus lifted their price objective on Align Technology from $200.00 to $210.00 and gave the company a “buy” rating in a research report on Thursday, February 5th. Seven equities research analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the company. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average target price of $198.08.
Read Our Latest Report on ALGN
Align Technology Profile
Align Technology, Inc (NASDAQ: ALGN) pioneered the use of digital technology in orthodontics through the development of the Invisalign system, a series of clear, removable aligners that provide an alternative to traditional metal braces. Since its founding in 1997 by Zia Chishti and Kelsey Wirth, the Tempe, Arizona–based company has expanded its focus to include intraoral scanners, CAD/CAM software for dental laboratories and comprehensive digital dentistry solutions.
The company’s signature Invisalign system leverages 3D imaging and computer-aided design (CAD) to create customized aligners that gradually reposition teeth, improving patient comfort and treatment predictability.
Read More
Want to see what other hedge funds are holding ALGN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Align Technology, Inc. (NASDAQ:ALGN – Free Report).
Receive News & Ratings for Align Technology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Align Technology and related companies with MarketBeat.com's FREE daily email newsletter.
